HOME | CONTACT | SITEMAP
  • HOME
  • CORPORATE
    • OUR COMPANY
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORY
      BOARD
    • CORPORATE GOVERNANCE
  • TECHNOLOGY
    • OUR PIPELINE
    • ABOUT CANCER STEM CELLS
    • THERAPEUTIC AREAS
  • INVESTORS
    • OUR BUSINESS AND
      POSITIONING
    • STOCK INFORMATION
    • FINANCIAL REPORTS
    • INVESTOR
      COMMUNICATIONS
    • SHAREHOLDER SERVICES
    • INVESTOR CONTACT
  • NEWS & EVENTS
    • PRESS RELEASES
    • EVENTS
    • PRESENTATIONS
  • TSX - Venture:  SSS
  • OUR BUSINESS AND POSITIONING
  • STOCK INFORMATION
  • FINANCIAL REPORTS
  • INVESTOR COMMUNICATIONS
  • SHAREHOLDER SERVICES
  • INVESTOR CONTACT

INDUSTRY NEWS
Dec. 4, 2011 Insight: Stem cell therapy poised to come in from the cold (REUTERS)
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade: 0.16
Change: +10.34%
Volume: 16230
Date: 5/22/2013
Time: 3:59pm

Note: Quotes are delayed. For informational purposes only.

©2004 - 2013 Stem Cell Therapeutics - All rights reserved
Home  |  Site Map  |  Terms Of Use |  Contact Us